Basel, Switzerland

Alexander Mayweg

USPTO Granted Patents = 37 

 

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 85(Granted Patents)


Location History:

  • Loerrach, DE (2007 - 2012)
  • Stony Brook, NY (US) (2021)
  • Basel, CH (2009 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
37 patents (USPTO):

Title: Innovations of Alexander Mayweg in Biomedicine

Introduction

Alexander Mayweg, located in Basel, Switzerland, is a prominent inventor in the field of biomedicine, holding an impressive portfolio of 37 patents. His work predominantly focuses on the development of modified proteins and targeted cancer treatments, showcasing his commitment to advancing healthcare through innovative solutions.

Latest Patents

Among his latest innovations, Mayweg has developed several notable patents. One of these includes "Modified IL-2 polypeptides and uses thereof," which details the creation of modified IL-2 polypeptides for therapeutic applications, particularly in cancer treatment. The inventions highlight preferential binding characteristics of the modified polypeptides to the IL-2 receptor beta-gamma complex over the alpha-beta-gamma complex. This specificity could lead to improved treatment outcomes for patients by minimizing side effects.

Another significant patent, "Tyrosine kinase inhibitor compositions, methods of making and methods of use," introduces novel compounds that act as inhibitors of receptor tyrosine kinases (RTK), specifically targeting extracellular mutants of ErbB receptors. These compounds hold promise in the treatment of cancers in mammals, including humans, signifying a substantial contribution to oncological therapeutics.

Career Highlights

Throughout his career, Alexander Mayweg has worked with renowned companies such as Hoffmann-La Roche Inc. and Siena Biotech S.p.a. These positions have afforded him the opportunity to refine his expertise in biomedical research and patent development, making substantial contributions to the field.

Collaborations

Mayweg has also collaborated with talented professionals in the industry, including coworkers Kurt E. Amrein and Bernd Kuhn. Their collective efforts have propelled innovations that are critical in addressing various medical challenges, particularly in cancer therapeutics.

Conclusion

Alexander Mayweg’s contributions to biomedicine through his numerous patents underscore his role as a leading innovator in the field. His ongoing research and collaborations continue to pave the way for new treatment options, demonstrating the significant impact of his work on health and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…